de la Fuente-Nunez is a presidential associate professor at the University of Pennsylvania. Skinner is CEO of the AMR Action Fund. Of all the areas of drug development that artificial intelligence has ...

To study this transformation, we compile a comprehensive, synchronized database spanning the pharmaceutical drug development supply chain, covering scientific publications, clinical trials, drug ...

Antibiotics are a crucial tool in the fight against bacterial infections. But the World Health Organization has long warned that we are facing an antibiotic crisis. Bacteria can easily adapt, evolve, ...

Researchers from the HUN-REN Biological Research Centre, Szeged (Hungary), have made a concerning discovery about the future of antibiotics. Two recent studies, published just days apart in Nature ...

Nobel laureate Sir Michael Houghton and colleagues at Applied Pharmaceutical Innovation (API) outline how rigorous early ...

Gram-negative bacteria such as E. coli are the most virulent class of drug-resistant bacteria. This week, the UN General Assembly will convene a meeting with world leaders to discuss the looming ...

When patient safety, regulatory approval and real-world effectiveness are on the line, AI can't act autonomously.

Soil plays a much bigger role in the spread of antibiotic resistance than one might imagine. Surprisingly, the ground beneath us is packed with antibiotic resistance genes (ARGs) - tiny codes that ...

B Capital, a global multi-stage investment firm, today announced that it has been selected as a registered venture capital firm under the Government of Japan’s Agency for Medical Research and ...

As the world grapples with the daunting challenge of antibiotic-resistant superbugs, a ray of hope emerges from the scientific community. Recent strides in medical research have led to the development ...